110 related articles for article (PubMed ID: 36863760)
1. Secondary validation of an ovarian cancer-specific comorbidity index in a US population.
Vranes C; Zhao H; Noer MC; Fu S; Sun CC; Harrison R; Ramirez PT; Høgdall CK; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2023 May; 33(5):749-754. PubMed ID: 36863760
[TBL] [Abstract][Full Text] [Related]
2. A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patients.
Noer MC; Sperling CD; Antonsen SL; Ottesen B; Christensen IJ; Høgdall C
Gynecol Oncol; 2016 Jun; 141(3):471-478. PubMed ID: 27056103
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity Assessment Using Charlson Comorbidity Index and Simplified Comorbidity Score and Its Association With Clinical Outcomes During First-Line Chemotherapy for Lung Cancer.
Singh N; Singh PS; Aggarwal AN; Behera D
Clin Lung Cancer; 2016 May; 17(3):205-213.e1. PubMed ID: 26589440
[TBL] [Abstract][Full Text] [Related]
4. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
5. Charlson Comorbidity Index is Associated With Longer-Term Mortality and Re-Admissions Following Coronary Artery Bypass Grafting.
Coyan GN; Chin H; Shah A; Miguelino AM; Wang Y; Kilic A; Sultan I; Sciortino CM; Chu D
J Surg Res; 2022 Jul; 275():300-307. PubMed ID: 35313139
[TBL] [Abstract][Full Text] [Related]
6. Type I Versus Type II Endometrial Cancer: Differential Impact of Comorbidity.
Noer MC; Antonsen SL; Ottesen B; Christensen IJ; Høgdall C
Int J Gynecol Cancer; 2018 Mar; 28(3):586-593. PubMed ID: 29303936
[TBL] [Abstract][Full Text] [Related]
7. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma.
Gordon MJ; Duan Z; Zhao H; Nastoupil L; Iyer S; Ferrajoli A; Danilov AV; Giordano SH
JCO Clin Cancer Inform; 2024 Apr; 8():e2300223. PubMed ID: 38684043
[TBL] [Abstract][Full Text] [Related]
9. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Vogel TJ; Goodman MT; Li AJ; Jeon CY
Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
[TBL] [Abstract][Full Text] [Related]
10. Impact of cardiovascular comorbidity on ovarian cancer mortality.
Shinn EH; Lenihan DJ; Urbauer DL; Basen-Engquist KM; Valentine A; Palmero L; Woods ML; Patel P; Nick AM; Shahzad MM; Stone RL; Golden A; Atkinson E; Lutgendorf SK; Sood AK
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2102-9. PubMed ID: 24045927
[TBL] [Abstract][Full Text] [Related]
11. Impact of Comorbidity Scores on the Overall Survival of Patients With Advanced Non-small Cell Lung Cancer: A Real-World Experience From Eastern India.
M SG; Mohapatra PR; Bhuniya S; Das Majumdar SK; Mishra P; Panigrahi MK; Bal SK; Datta A; Venkatachalam P; Chatterjee D
Cureus; 2022 Oct; 14(10):e30589. PubMed ID: 36420233
[TBL] [Abstract][Full Text] [Related]
12. A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.
Garcia C; Yao A; Camacho F; Balkrishnan R; Cantrell LA
Gynecol Oncol; 2017 Aug; 146(2):346-350. PubMed ID: 28499649
[TBL] [Abstract][Full Text] [Related]
13. Modified Charlson comorbidity index for predicting survival after liver transplantation.
Volk ML; Hernandez JC; Lok AS; Marrero JA
Liver Transpl; 2007 Nov; 13(11):1515-20. PubMed ID: 17969207
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
15. Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy.
Lyons YA; Reyes HD; McDonald ME; Newtson A; Devor E; Bender DP; Goodheart MJ; Gonzalez Bosquet J
Int J Gynecol Cancer; 2020 Jun; 30(6):845-852. PubMed ID: 32341114
[TBL] [Abstract][Full Text] [Related]
16. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Meyers J; Yu Y; Kaye JA; Davis KL
Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
[TBL] [Abstract][Full Text] [Related]
17. Comparing survival of older ovarian cancer patients treated with neoadjuvant chemotherapy versus primary cytoreductive surgery: Reducing bias through machine learning.
Huang Y; Rauh-Hain JA; McCoy TH; Hou JY; Hillyer G; Ferris JS; Hershman D; Wright JD; Melamed A
Gynecol Oncol; 2024 Mar; 186():9-16. PubMed ID: 38554626
[TBL] [Abstract][Full Text] [Related]
18. Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus.
Jönsen A; Clarke AE; Joseph L; Belisle P; Bernatsky S; Nived O; Bengtsson AA; Sturfelt G; Pineau CA
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1233-7. PubMed ID: 21618451
[TBL] [Abstract][Full Text] [Related]
19. Charlson comorbidity index is an important prognostic factor for long-term survival outcomes in Korean men with prostate cancer after radical prostatectomy.
Lee JY; Lee DH; Cho NH; Rha KH; Choi YD; Hong SJ; Yang SC; Cho KS
Yonsei Med J; 2014 Mar; 55(2):316-23. PubMed ID: 24532498
[TBL] [Abstract][Full Text] [Related]
20. Predicting mortality of incident dialysis patients in Taiwan--a longitudinal population-based study.
Wu PH; Lin YT; Lee TC; Lin MY; Kuo MC; Chiu YW; Hwang SJ; Chen HC
PLoS One; 2013; 8(4):e61930. PubMed ID: 23626754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
